• Bookmarks
    • Add bookmark
  • Login
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact
Close
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact

All Investigators

HomeAll Investigators
Dr. Victor Puntes

Dr. Victor Puntes

Started 13 September, 2016 3596

Head of Group Email: victor.puntes@vhir.org Phone: 934894984 / ext 4984

Read more
Dr. Joan López Hellín

Dr. Joan López Hellín

Started 12 September, 2016 3126

Senior Investigator Email: joan.lopez.hellin@vhir.org Phone: 934894072/ ext4072

Read more
Dra. Anna Meseguer Navarro

Dra. Anna Meseguer Navarro

Started 12 September, 2016 4133

Head of Group Email: ana.meseguer@vhir.org Phone: +34934894061 / ext 4061

Read more

Dr. José Raúl Herance

Started 11 September, 2016 3954

Senior Investigator Email: raul.herance@vhir.org Phone: 934894055

Read more
Dr. Vicenç Martínez Ibáñez

Dr. Vicenç Martínez Ibáñez

Started 11 September, 2016 3821

Head of Group Email: vimartin@vhebron.net Phone: 934893098 / ext 3098

Read more
Dr. Manuel Galiñanes Hernández

Dr. Manuel Galiñanes Hernández

Started 7 September, 2016 3979

Head of Group Email: manuel.galinanes@vhir.org Phone: 932746160 / ext 4663

Read more

Dra. Mari Carmen Domínguez Luengo

Started 6 September, 2016 3421

Science Advisor Email: carmen.dominguez@vhir.org Phone: 934894066/ ext4066

Read more
Joan Castell Conesa

Joan Castell Conesa

Started 6 September, 2016 3786

Head of Group Email: jcastell@vhebron.net Phone: 932746121 / ext 6369

Read more
Dra. Coro Bescós Atin

Dra. Coro Bescós Atin

Started 5 September, 2016 4133

Head of Group Email: 24342sba@comb.es Phone: 932746179 / ext 6179/637

Read more
Dra. Eva Baldrich Rubio

Dra. Eva Baldrich Rubio

Started 4 September, 2016 4005

Head of Group Email: eva.baldrich@vhir.org Phone: 934893754 / ext 3754

Read more

Dra. Gemma Ariceta Iraola

Started 3 September, 2016 3461

Senior Investigator Email: gariceta@vhebron.net Phone: 934893082/ ext3082

Read more
Dr. Diego Arango del Corro

Dr. Diego Arango del Corro

Started 2 September, 2016 4923

Head of Group Email: diego.arango@vhir.org Phone: 932746739 / ext 6739

Read more
…6789
Search
Categories
  • About-us
  • Biomedical Research in Digestive Tumors
  • Drug Delivery and Targeting
  • events
  • Immune Regulation and Immunotherapy Group
  • Kidney Physiopathology
  • New Technologies and Craniofacial Microsurgery
  • News
  • Pharmacokinetic Nanoparticles
  • Publications
  • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
  • Uncategorized
Recent Posts
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
9 days agoby CIBBIM - Nanomedicine0
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
24 February, 2020by CIBBIM - Nanomedicine0
Tags
CLINICAL APPLICATION OF NANOMEDICINE ESNAM EUROPEAN SOCIETY FOR NANOMEDICINE INTERNATIONAL SOCIETY OF NANOMEDICINE ISN
Contact Us
CIBBIM-Nanomedicine
Institut de Recerca
Hospital Universitari Vall d'Hebron
Passeig Vall d'Hebron, 119-129-
08035 Barcelona - Spain
Tel: +34 93 489 4055
Fax: +34 93 489 4040
  • Email: info@cibbim.eu


CIBBIM-Nanomedicine laboratories are located within VHIR’s premises (Mediterrània and Collserola buildings, in violet), Bus lines and Metro stations (Line Green (L3); stops of Montbau and Vall d’Hebron) are also indicated.

ACCESS MAP LOCAL
Albertino © 2014 All Rights Reserved
Forgot password?
You can login using your social profile
Problem with login?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More